Skip to main content

2019 | OriginalPaper | Buchkapitel

2. Reaktive unilineäre Zytopenien und Zytosen

verfasst von : Prof. Dr. Hans H. Kreipe

Erschienen in: Pathologie

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Wichtigstes Prinzip der Diagnostik ist die Definition des Zuviel und Zuwenig einzelner Blutbildungsreihen oder der hämopoetischen Potenz des Knochenmarks. Die vielfältigen Formen, ihre morphologischen und funktionellen Befunde bei Anämien und bei Erythrozytose, die angeborenen und reaktiven Formen der Störungen der Granulozytopoese und Monozytopoese, isolierte Vermehrungen einzelner Granulozytenarten und die nicht neoplastischen Erkrankungen der Thrombozytopoese werden in diesem Kapitel dargestellt. Die Befunde, in denen die morphologische Diagnostik allein oft an ihre Grenzen stößt, werden übersichtlich zusammengefasst, so dass immer eine komprehensive diagnostische Gesamtschau und Differenzialdiagnose der Krankheitsbilder und ihrer Pathogenese resultiert.
Literatur
1.
Zurück zum Zitat Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN (2015) Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood 125:616–618CrossRefPubMed Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN (2015) Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood 125:616–618CrossRefPubMed
2.
3.
Zurück zum Zitat Bain BJ (2005) Diagnosis from the blood smear. N Engl J Med 353:498–507CrossRef Bain BJ (2005) Diagnosis from the blood smear. N Engl J Med 353:498–507CrossRef
4.
Zurück zum Zitat Barcellini W, Fattizzo B (2015) Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers 2015:635670CrossRefPubMed Barcellini W, Fattizzo B (2015) Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers 2015:635670CrossRefPubMed
5.
Zurück zum Zitat Berentsen S, Randen U, Tjønnfjord GE (2015) Cold agglutinin-mediated autoimmune hemolytic anemia. Hematol Oncol Clin North Am 29:455–471CrossRef Berentsen S, Randen U, Tjønnfjord GE (2015) Cold agglutinin-mediated autoimmune hemolytic anemia. Hematol Oncol Clin North Am 29:455–471CrossRef
6.
Zurück zum Zitat Beutler E (2008) Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111:16–24CrossRef Beutler E (2008) Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111:16–24CrossRef
7.
Zurück zum Zitat Boyer DF (2016) Blood and bone marrow evaluation for eosinophilia. Arch Pathol Lab Med 140:1060–1067CrossRef Boyer DF (2016) Blood and bone marrow evaluation for eosinophilia. Arch Pathol Lab Med 140:1060–1067CrossRef
8.
Zurück zum Zitat Boxer LA (2012) How to approach neutropenia. Hematology Am Soc Hematol Educ Program 2012:174–182PubMed Boxer LA (2012) How to approach neutropenia. Hematology Am Soc Hematol Educ Program 2012:174–182PubMed
10.
Zurück zum Zitat Brodsky RA (2015) Complement in hemolytic anemia. Blood 126:2459–2465CrossRef Brodsky RA (2015) Complement in hemolytic anemia. Blood 126:2459–2465CrossRef
11.
Zurück zum Zitat Carmel R, Green R, Rosenblatt DS, Watkins D (2003) Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003:62–81 Carmel R, Green R, Rosenblatt DS, Watkins D (2003) Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program 2003:62–81
12.
Zurück zum Zitat Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995–1008CrossRef Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995–1008CrossRef
13.
Zurück zum Zitat Da Costa L, Galimand J, Fenneteau O, Mohandas N (2013) Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev 27:167–178CrossRef Da Costa L, Galimand J, Fenneteau O, Mohandas N (2013) Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev 27:167–178CrossRef
14.
Zurück zum Zitat Dale DC, Welte K (2011) Cyclic and chronic neutropenia. Cancer Treat Res 157:97–108CrossRef Dale DC, Welte K (2011) Cyclic and chronic neutropenia. Cancer Treat Res 157:97–108CrossRef
15.
Zurück zum Zitat Dotta L, Tassone L, Badolato R (2011) Clinical and genetic features of Warts, hypogammaglobulinemia, infections and myelokathexis (WHIM) syndrome. Curr Mol Med 11:317–325CrossRef Dotta L, Tassone L, Badolato R (2011) Clinical and genetic features of Warts, hypogammaglobulinemia, infections and myelokathexis (WHIM) syndrome. Curr Mol Med 11:317–325CrossRef
16.
Zurück zum Zitat Garaycoechea JI, Patel KJ (2014) Why does the bone marrow fail in Fanconi anemia? Blood 123:26–34CrossRef Garaycoechea JI, Patel KJ (2014) Why does the bone marrow fail in Fanconi anemia? Blood 123:26–34CrossRef
17.
Zurück zum Zitat George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666CrossRef George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654–666CrossRef
19.
Zurück zum Zitat Greer JP, Arber DA, Rodgers GM (2013) Wintrobe’s clinical hematology. Lippincott Williams & Wilkins, Philadelphia Greer JP, Arber DA, Rodgers GM (2013) Wintrobe’s clinical hematology. Lippincott Williams & Wilkins, Philadelphia
20.
Zurück zum Zitat Harrington AM, Ward PC, Kroft SH (2008) Iron deficiency anemia, beta-thalassemia minor, and anemia of chronic disease: a morphologic reappraisal. Am J Clin Pathol 129:466–471CrossRef Harrington AM, Ward PC, Kroft SH (2008) Iron deficiency anemia, beta-thalassemia minor, and anemia of chronic disease: a morphologic reappraisal. Am J Clin Pathol 129:466–471CrossRef
21.
Zurück zum Zitat Hauck F, Klein C (2013) Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr Opin Allergy Clin Immunol 13:596–606CrossRef Hauck F, Klein C (2013) Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr Opin Allergy Clin Immunol 13:596–606CrossRef
22.
Zurück zum Zitat Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E (2003) Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 102:4576–4581CrossRef Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, Griesshammer A, Marquardt T, Janka-Schaub G, Kron M, Kohne E (2003) Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 102:4576–4581CrossRef
23.
Zurück zum Zitat Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 107:334–340CrossRef Heimpel H, Schwarz K, Ebnöther M, Goede JS, Heydrich D, Kamp T, Plaumann L, Rath B, Roessler J, Schildknecht O, Schmid M, Wuillemin W, Einsiedler B, Leichtle R, Tamary H, Kohne E (2006) Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation. Blood 107:334–340CrossRef
24.
Zurück zum Zitat Hershko C, Skikne B (2009) Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis. Semin Hematol 46:339–350CrossRef Hershko C, Skikne B (2009) Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis. Semin Hematol 46:339–350CrossRef
25.
Zurück zum Zitat Hershko C, Camaschella C (2014) How I treat unexplained refractory iron deficiency anemia. Blood 123:326–333CrossRef Hershko C, Camaschella C (2014) How I treat unexplained refractory iron deficiency anemia. Blood 123:326–333CrossRef
26.
Zurück zum Zitat Imataki O, Ohnishi H, Kitanaka A, Kubota Y, Ishida T, Tanaka T (2008) Pancytopenia complicated with peripheral neuropathy due to copper deficiency: clinical diagnostic review. Intern Med 47:2063–2065CrossRef Imataki O, Ohnishi H, Kitanaka A, Kubota Y, Ishida T, Tanaka T (2008) Pancytopenia complicated with peripheral neuropathy due to copper deficiency: clinical diagnostic review. Intern Med 47:2063–2065CrossRef
27.
Zurück zum Zitat Jenkins SJ, Hume DA (2014) Homeostasis in the mononuclear phagocyte system. Trends Immunol 35:358–367CrossRef Jenkins SJ, Hume DA (2014) Homeostasis in the mononuclear phagocyte system. Trends Immunol 35:358–367CrossRef
28.
Zurück zum Zitat Karpman D, Loos S, Tati R, Arvidsson I (2016) Haemolytic uraemic syndrome. J Intern Med 281:123–148CrossRef Karpman D, Loos S, Tati R, Arvidsson I (2016) Haemolytic uraemic syndrome. J Intern Med 281:123–148CrossRef
29.
Zurück zum Zitat Latvala J, Parkkila S, Niemelä O (2004) Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res 28:619–624CrossRef Latvala J, Parkkila S, Niemelä O (2004) Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res 28:619–624CrossRef
31.
32.
Zurück zum Zitat Löffler H, Haferlach T (2013) Hämatologische Erkrankungen. Springer, HeidelbergCrossRef Löffler H, Haferlach T (2013) Hämatologische Erkrankungen. Springer, HeidelbergCrossRef
33.
Zurück zum Zitat Longerich S, Li J, Xiong Y, Sung P, Kupfer GM (2014) Stress and DNA repair biology of the Fanconi anemia pathway. Blood 124:2812–2819CrossRefPubMed Longerich S, Li J, Xiong Y, Sung P, Kupfer GM (2014) Stress and DNA repair biology of the Fanconi anemia pathway. Blood 124:2812–2819CrossRefPubMed
34.
Zurück zum Zitat May A, Fitzsimons E (1994) Sideroblastic anaemia. Baillieres Clin Haematol 7:851–879CrossRef May A, Fitzsimons E (1994) Sideroblastic anaemia. Baillieres Clin Haematol 7:851–879CrossRef
35.
36.
Zurück zum Zitat Naik R (2015) Warm autoimmune hemolytic anemia. Hematol Oncol Clin North Am 29:445–453CrossRef Naik R (2015) Warm autoimmune hemolytic anemia. Hematol Oncol Clin North Am 29:445–453CrossRef
37.
Zurück zum Zitat Narla A, Vlachos A, Nathan DG (2011) Diamond Blackfan anemia treatment: past, present, and future. Semin Hematol 48:117–123CrossRefPubMed Narla A, Vlachos A, Nathan DG (2011) Diamond Blackfan anemia treatment: past, present, and future. Semin Hematol 48:117–123CrossRefPubMed
38.
Zurück zum Zitat Newburger PE, Dale DC (2013) Evaluation and management of patients with isolated neutropenia. Semin Hematol 50:198–206CrossRefPubMed Newburger PE, Dale DC (2013) Evaluation and management of patients with isolated neutropenia. Semin Hematol 50:198–206CrossRefPubMed
39.
Zurück zum Zitat Quist E, Koepsell S (2015) Autoimmune hemolytic anemia and red blood cell autoantibodies. Arch Pathol Lab Med 139:1455–1458CrossRefPubMed Quist E, Koepsell S (2015) Autoimmune hemolytic anemia and red blood cell autoantibodies. Arch Pathol Lab Med 139:1455–1458CrossRefPubMed
40.
Zurück zum Zitat Parikh S, Bessler M (2012) Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr 24:23–32CrossRefPubMed Parikh S, Bessler M (2012) Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr 24:23–32CrossRefPubMed
41.
42.
Zurück zum Zitat Piel FB, Weatherall DJ (2014) The α-thalassemias. N Engl J Med 371:1908–1916CrossRef Piel FB, Weatherall DJ (2014) The α-thalassemias. N Engl J Med 371:1908–1916CrossRef
43.
Zurück zum Zitat Preis M, Lowrey CH (2014) Laboratory tests for paroxysmal nocturnal hemoglobinuria. Am J Hematol 89:339–341CrossRef Preis M, Lowrey CH (2014) Laboratory tests for paroxysmal nocturnal hemoglobinuria. Am J Hematol 89:339–341CrossRef
44.
45.
Zurück zum Zitat Rund D, Rachmilewitz E (2001) Beta-thalassemia. N Engl J Med 353:1135–1146CrossRef Rund D, Rachmilewitz E (2001) Beta-thalassemia. N Engl J Med 353:1135–1146CrossRef
46.
Zurück zum Zitat Seidel MG (2014) Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood 124:2337–2344CrossRefPubMed Seidel MG (2014) Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood 124:2337–2344CrossRefPubMed
47.
Zurück zum Zitat Shenkman B, Einav Y (2014) Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev 13:584–586CrossRef Shenkman B, Einav Y (2014) Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev 13:584–586CrossRef
48.
Zurück zum Zitat Stein SM, Dale DC (2003) Molecular basis and therapy of disorders associated with chronic neutropenia. Curr Allergy Asthma Rep 3:385–388CrossRef Stein SM, Dale DC (2003) Molecular basis and therapy of disorders associated with chronic neutropenia. Curr Allergy Asthma Rep 3:385–388CrossRef
49.
Zurück zum Zitat Sulai NH, Tefferi A (2012) Why does my patient have thrombocytosis? Hematol Oncol Clin North Am 26:285–301CrossRef Sulai NH, Tefferi A (2012) Why does my patient have thrombocytosis? Hematol Oncol Clin North Am 26:285–301CrossRef
50.
Zurück zum Zitat Telen MJ (2016) Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease. Blood 127:810–819CrossRefPubMed Telen MJ (2016) Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease. Blood 127:810–819CrossRefPubMed
51.
Zurück zum Zitat Trakadis YJ, Alfares A, Bodamer OA, Buyukavci M, Christodoulou J, Connor P, Glamuzina E, Gonzalez-Fernandez F, Bibi H, Echenne B, Manoli I, Mitchell J, Nordwall M, Prasad C, Scaglia F, Schiff M, Schrewe B, Touati G, Tchan MC, Varet B, Venditti CP, Zafeiriou D, Rupar CA, Rosenblatt DS, Watkins D, Braverman N (2014) Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis 37:461–473CrossRef Trakadis YJ, Alfares A, Bodamer OA, Buyukavci M, Christodoulou J, Connor P, Glamuzina E, Gonzalez-Fernandez F, Bibi H, Echenne B, Manoli I, Mitchell J, Nordwall M, Prasad C, Scaglia F, Schiff M, Schrewe B, Touati G, Tchan MC, Varet B, Venditti CP, Zafeiriou D, Rupar CA, Rosenblatt DS, Watkins D, Braverman N (2014) Update on transcobalamin deficiency: clinical presentation, treatment and outcome. J Inherit Metab Dis 37:461–473CrossRef
52.
Zurück zum Zitat Valent P (2009) Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev 23:157–165CrossRef Valent P (2009) Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders. Blood Rev 23:157–165CrossRef
53.
Zurück zum Zitat Wickramasinghe SN (2006) Diagnosis of megaloblastic anaemias. Blood Rev 20:299–318CrossRef Wickramasinghe SN (2006) Diagnosis of megaloblastic anaemias. Blood Rev 20:299–318CrossRef
54.
Zurück zum Zitat Yan M, Malinowski AK, Shehata N (2016) Thrombocytopenic syndromes in pregnancy. Obstet Med 9:15–20CrossRef Yan M, Malinowski AK, Shehata N (2016) Thrombocytopenic syndromes in pregnancy. Obstet Med 9:15–20CrossRef
55.
Zurück zum Zitat Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350:586–597CrossRef Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350:586–597CrossRef
Metadaten
Titel
Reaktive unilineäre Zytopenien und Zytosen
verfasst von
Prof. Dr. Hans H. Kreipe
Copyright-Jahr
2019
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-540-85184-4_2

Neu im Fachgebiet Pathologie